Competition among pharmacies and the typology of services delivered: The Portuguese case

Health Policy

Volumn 119, Issue 5, 2015, Pages 640-647

  Martins, Lurdes ^a   Queirós, Sónia ^b  

^a UNIVERSITY OF MINHO   (Portugal)

^b Centro de Estudos de Farmacoepidemiologia   (Portugal)

Author keywords

Community pharmacy services; Pro competitive regulation; Social welfare effects

Indexed keywords

BUPRENORPHINE; METHADONE; NALTREXONE; VACCINE;

ARTICLE; ASTHMA; COMPETITION; DIABETES MELLITUS; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; HYPERTENSION; MARKETING; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; RURAL AREA; SMOKING CESSATION; URBAN AREA; VACCINATION; COMMERCIAL PHENOMENA; ECONOMIC ASPECT; ECONOMICS; GOVERNMENT REGULATION; LEGISLATION AND JURISPRUDENCE; PORTUGAL; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; URBAN POPULATION;

COMMERCE; ECONOMIC COMPETITION; GOVERNMENT REGULATION; HEALTH SERVICES ACCESSIBILITY; PHARMACIES; PORTUGAL; SURVEYS AND QUESTIONNAIRES; URBAN POPULATION;

EID: 84933674907     PISSN: 01688510     EISSN: 18726054     Source Type: Journal    
DOI: 10.1016/j.healthpol.2015.03.001     Document Type: Article

References (25)

1. Kanavos P., Schurer W., Vogler S. The pharmaceutical distribution chain in the European Union: structure and impact on pharmaceutical prices, Eminet report 2011, European Commission, Brussels.
2. ANF - National Association of Pharmacies Internal monthly report "Observatório da Farmácia" 2012, CEFAR, Lisbon.
3. Barros P.P., Martins B., Moura A. The rocky road to market equilibrium: price regulation and entry liberalization in the Portuguese retail pharmacy. Value Health 2012, 15(7):A321.
4. Hou X., Velényi E.V., Yazbeck A.S., Iunes R.F., Smith O. Learning from economic downturns: how to better assess, track, and mitigate the impact on the health sector 2013, World Bank, Washington, DC.
5. INFARMED Estatísticas do Medicamento 2012, Lisboa.
6. Instituto Nacional de Estatística (INE), Statistical data, URL:. http://www.ine.pt/xportal/xmain?xpid=INE%26xpgid=ine_base_dados%26contexto=bd%26selTab=tab2%26xlang=en.
7. PGEU - Pharmaceutical Group of the European Union Annual report, Brussels 2012.
8. Office of Fair Trading The control of entry regulations and retail pharmacy services in the UK - a report of an OFT market investigation 2003, OFT, London.
9. Office of Fair Trading Evaluating the impact of the 2003 OFT study on the Control of Entry regulations in the retail pharmacies market 2010, Prepared for the Office of Fair Trading by DotEcon, London.
10. Nordic Competition Authorities Competition challenges in the pharmacy/pharmaceutical sector. Executive summary of report from the Nordic Competition authorities, no. 1/2008 2008.
11. Power D. An economic analysis of the Irish retail pharmacy Market with a focus on competition policy issues 2004, vol. 18. Student Economic Review, Dublin.
12. Brekke K., Siciliani L., Straume O. Hospital competition and quality with regulated prices. Scandinavian Journal of Economics 2011, 113(2):444-469.
13. Bayus B., Putsis W. Product proliferation: an empirical analysis of product line determinants and market outcomes. Marketing Science 1999, 8(2):137-153.
14. Doucette W., Kreling D., Schommer J., Gaither C., Mott D., Pedersen C. Evaluation of community pharmacy service mix: evidence from the 2004 national pharmacist workforce study. Journal of the American Pharmacists Association 2006, 46(3):348-355.
15. Brooks J., Doucette W., Wan S., Klepser D. Retail pharmacy market structure and performance. Journal of Health Care Organization Provision and Financing 2008, 45:75-88.
16. Brooks J., Klepser D., Urmie J., Farris K., Doucette W. Effect of local competition on the willingness of community pharmacies to supply medication therapy management services. Journal of Health and Human Services Administration 2007, 30:4-27.
17. Office of Fair Trading The relationship between quality and local concentration - OFT Pharmacy Investigation 2002, Frontier Economics, London.
18. Berry S., Waldfogel J. Product quality and market size. The Journal of Industrial Economics 2010, 58(1):1-31.
19. Doucette W., Brooks J., Sorofman B., Wong H. Market factors and the availability of community pharmacies. Clinical Therapeutics 1999, 21(7):1267-1279.
20. Porell F., Liu K., Brungo D. Agency and market area factors affecting home health agency supply changes. Health Services Research 2006, 41(5):1847-1875.
21. Jung K., Polsky D. Competition and quality in home health care markets. Health Economics 2014, 23:298-313.
22. Mangano A. Community pharmacies in the city area: evidence from an Italian province. European Planning Studies 2010, 18(3):485-496.
23. Cappellari L., Jenkins S. Multivariate probit regression using simulated maximum likelihood. The Stata Journal 2003, 3(3):278-294.
24. Anell A. Deregulating the pharmacy market: the case of Iceland and Norway. Health Policy 2005, 75:9-17.
25. Vogler S., Habimana K., Arts D. Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries. Health Policy 2014, 117(3):311-327.